Isolation, characterization, anti-MRSA evaluation, and in-silico multi-target anti-microbial validations of actinomycin X2 and actinomycin D produced by novel Streptomyces smyrnaeus UKAQ_23
-
Published:2021-07-15
Issue:1
Volume:11
Page:
-
ISSN:2045-2322
-
Container-title:Scientific Reports
-
language:en
-
Short-container-title:Sci Rep
Author:
Qureshi Kamal A.,Bholay Avinash D.,Rai Pankaj K.,Mohammed Hamdoon A.,Khan Riaz A.,Azam Faizul,Jaremko Mariusz,Emwas Abdul-Hamid,Stefanowicz Piotr,Waliczek Mateusz,Kijewska Monika,Ragab Ehab A.,Rehan Medhat,Elhassan Gamal O.,Anwar Md Jamir,Prajapati Dinesh K.
Abstract
AbstractStreptomyces smyrnaeus UKAQ_23, isolated from the mangrove-sediment, collected from Jubail,Saudi Arabia, exhibited substantial antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA), including non-MRSA Gram-positive test bacteria. The novel isolate, under laboratory-scale conditions, produced the highest yield (561.3 ± 0.3 mg/kg fermented agar) of antimicrobial compounds in modified ISP-4 agar at pH 6.5, temperature 35 °C, inoculum 5% v/w, agar 1.5% w/v, and an incubation period of 7 days. The two major compounds, K1 and K2, were isolated from fermented medium and identified as Actinomycin X2 and Actinomycin D, respectively, based on their structural analysis. The antimicrobial screening showed that Actinomycin X2 had the highest antimicrobial activity compared to Actinomycin D, and the actinomycins-mixture (X2:D, 1:1, w/w) against MRSA and non-MRSA Gram-positive test bacteria, at 5 µg/disc concentrations. The MIC of Actinomycin X2 ranged from 1.56–12.5 µg/ml for non-MRSA and 3.125–12.5 µg/ml for MRSA test bacteria. An in-silico molecular docking demonstrated isoleucyl tRNA synthetase as the most-favored antimicrobial protein target for both actinomycins, X2 and D, while the penicillin-binding protein-1a, was the least-favorable target-protein. In conclusion, Streptomyces smyrnaeus UKAQ_23 emerged as a promising source of Actinomycin X2 with the potential to be scaled up for industrial production, which could benefit the pharmaceutical industry.
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Reference92 articles.
1. Inweregbu, K., Dave, J. & Pittard, A. Nosocomial infections. Contin. Educ. Anaesthesia Crit. Care Pain 5, 14–17. https://doi.org/10.1093/bjaceaccp/mki006 (2005). 2. Maiti, P. K., Das, S., Sahoo, P. & Mandal, S. Streptomyces sp SM01 isolated from Indian soil produces a novel antibiotic picolinamycin effective against multi drug resistant bacterial strains. Sci. Rep. 10, 10092. https://doi.org/10.1038/s41598-020-66984-w (2020). 3. Qureshi, K. A., Bholay, A. D., Elhassan, G. O., Khan, R. A. & El-Agamy, E. I. Isolation, purification and characterization of bacteriocin produced by Bacillus pumilus NJ-M2; a future biopreservative. Int. J. Biol. Pharmacy Allied Sci. 5, 2840–2862 (2016). 4. Alanazi, A. S., Qureshi, K. A., Elhassan, G. O. & El-Agamy, E. I. Isolation, purification and characterization of antimicrobial agent antagonistic to Escherichia coli ATCC 10536 produced by Bacillus pumilus SAFR-032 isolated from the soil of Unaizah, Al Qassim province of Saudi Arabia. Pak. J. Biol. Sci. 19, 191–201. https://doi.org/10.3923/pjbs.2016.191.201 (2016). 5. Aislabie, J., Deslippe, J. R. & Dymond, J. R. Soil microbes and their contribution to soil services. Ecosyst. Serv. New Zeal. Cond. trends 2, 143–161 (2013).
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|